2007
DOI: 10.1016/j.antiviral.2006.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
54
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(56 citation statements)
references
References 20 publications
1
54
0
Order By: Relevance
“…The pharmacology of PAL is, however, still unclear. Some pharmacological studies have shown that PAL possesses a number of biological activities, including inhibition of HBV DNA replication and HBV antigen expression (28) and inhibition of cytokine-induced VCAM-1 and ICAM-1 expression (29). In this study, we found that PAL has DJ-1-dependent anti-oxidative activity.…”
Section: Discussionsupporting
confidence: 49%
“…The pharmacology of PAL is, however, still unclear. Some pharmacological studies have shown that PAL possesses a number of biological activities, including inhibition of HBV DNA replication and HBV antigen expression (28) and inhibition of cytokine-induced VCAM-1 and ICAM-1 expression (29). In this study, we found that PAL has DJ-1-dependent anti-oxidative activity.…”
Section: Discussionsupporting
confidence: 49%
“…These roles may take place at the transcription and post-transcription levels. 31) Therefore, the HBV mRNA level was determined in HepG2.2.15 cells. The results revealed that HBV antigen inhibition by cinobufacini, bufalin, and cinobufagin was attributed to the specific inhibition of HBV mRNA expression.…”
Section: Discussionmentioning
confidence: 99%
“…This role may take place at the transcription level (22). HBV enhancers, the transcriptional regulatory DNA fragments, may mediate the transcriptional suppression by binding several transcription factors.…”
Section: Discussionmentioning
confidence: 99%